Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD ▼ | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc. | 3.560% | 9.605% | -9.946% | -68.785% | 18.403% | -94.648% | - |
| Anika Therapeutics | - | -1.667% | -3.279% | -4.839% | 15.686% | -32.571% | -29.033% |
| Aclaris Therapeutics Inc | 3.510% | 1.387% | -4.194% | -86.208% | 15.421% | -94.098% | - |
| Xencor Inc. | 2.800% | 10.553% | 27.907% | -16.031% | 15.183% | -33.454% | -23.558% |
| Blueprint Medicines Corp | -1.050% | -3.384% | 9.903% | 73.908% | 14.885% | 22.740% | - |
| Collegium Pharmaceutical Inc | - | 3.974% | -6.548% | 46.729% | 14.599% | 59.391% | - |
| Ani Pharmaceuticals Inc. | -1.750% | -4.202% | -6.557% | 31.336% | 14.458% | 96.552% | -9.207% |
| Codexis Inc. | 1.440% | -7.024% | 19.453% | 25.779% | 14.377% | -79.938% | -81.418% |
| Genfit S.A. | -0.480% | 19.275% | 26.615% | 7.022% | 14.147% | 25.000% | -80.367% |
| Regeneron Pharmaceuticals Inc. | 0.330% | 1.886% | 7.055% | 30.467% | 13.781% | 118.177% | 224.071% |
| Vertex Pharmaceuticals Inc. | 0.650% | 2.848% | 10.299% | 34.673% | 12.243% | 138.126% | 169.372% |
| Neurocrine Bioscience | 0.040% | -0.498% | -0.725% | 49.494% | 8.969% | 68.394% | 83.980% |
| Amgen Inc. | -0.560% | -2.106% | 10.935% | 35.930% | 8.807% | 37.646% | 85.254% |
| Lexicon Pharmaceuticals Inc. | -4.200% | -11.955% | -1.515% | -47.359% | 8.333% | -58.170% | -74.414% |
| Aldeyra Therapeutics Inc. | -1.680% | -6.837% | -4.029% | -61.580% | 7.820% | - | - |
| SCYNEXIS Inc. | -14.680% | -5.707% | 43.290% | -19.302% | 6.116% | -70.593% | - |
| Biocryst Pharmaceuticals | -1.980% | -1.479% | 43.395% | -27.914% | 5.927% | -48.443% | 83.245% |
| AbbVie Inc. | -0.690% | -3.173% | -7.538% | 10.703% | 4.540% | 53.683% | 102.237% |
| Chimerix Inc. | -2.780% | -2.354% | 0.577% | -34.659% | 3.765% | -86.327% | -72.047% |